Growth Metrics

Invivyd (IVVD) Leases (2022 - 2025)

Invivyd posted quarterly Leases of $2.4 million for Q4 2025, up 76.32% year-on-year from $1.4 million in Q4 2024, and down 10.48% on a QoQ basis from $2.7 million in Q3 2025.

Invivyd (IVVD) has 4 years of Leases data on file, last reported at $2.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Leases rose 76.32% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 76.32% YoY), and the FY2025 full-year result was $2.4 million, up 76.32% from the prior year.
  • Leases for Q4 2025 stood at $2.4 million, down from $2.7 million in the prior quarter.
  • Across five years, Leases topped out at $3.8 million in Q4 2022 and bottomed at $782000.0 in Q2 2024.
  • The 4-year median for Leases is $2.3 million (2023), against an average of $2.2 million.
  • The widest annual swing landed in 2024, when Leases slumped 74.05%; it then surged 284.91% in 2025.
  • A 4-year view of Leases shows it stood at $3.8 million in 2022, then tumbled by 40.98% to $2.2 million in 2023, then sank by 37.86% to $1.4 million in 2024, then surged by 76.32% to $2.4 million in 2025.
  • The last three Leases figures came in at $2.4 million (Q4 2025), $2.7 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 2.44 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.44 Mn
Sep 30, 2025 2.73 Mn
Jun 30, 2025 3.01 Mn
Mar 31, 2025 953,000.00
Dec 31, 2024 1.39 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 782,000.00
Mar 31, 2024 1.83 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.63 Mn
Jun 30, 2023 3.01 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 3.78 Mn
Sep 30, 2022 1.49 Mn
Jun 30, 2022 2.86 Mn
Mar 31, 2022 1.65 Mn